A Study to Evaluate the Safety and Clinical Response of Subretinal Administration of CNTO 2476 in Participants With Geographic Atrophy
Clinical trial NCT02659098 · COMPLETED
Trial details
- NCT number
- NCT02659098
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-04
- Primary completion
- 2019-06-05
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.